Transplant Overview + Drugs Flashcards
mycophenolate
First-line Antiproliferative agent
MOA: inhibits T-lymphocytes proliferation by altering purine synthesis
Class: antiproliferative agent
Brands: CellCept & Myfortic not interchangeable
SE: causes diarrhea (less with myfortic bc enteric coated
Notes: CellCept IV - D5W only; decrease PO contraceptives
tacrolimus
First-line CNI
MOA: inhibits T-lymphocyte activation
Class: calcineurin inhibitor
Brands: Prograf (w/ or w/o food); Astagraf XL (oes)
SE: increase BP/BG, neuro/nephrotoxic, QT prolongation, hyperlipidemia
Notes: IV must be administered in non-PVC bag; CYP3A4 and P-gp substrate
Which agent is associated with a genetic deficiency of thiopurine methyltransferase (TPMT) and increase risk for myelosuppression?
azathioprine (Azasan, Imuran)
antithymocyte globulins
MOA: binds to T-lymphocytes (killer cells) and interferes with their function
Agents: Atgam - Equine | Thymoglobulin - Rabbit
SE: infusion-related rxns
Notes: premedicate (diphenhydramine, APAP, steroids) to lessen rxn
induction immunosuppressants
1) basiliximab, IL-2 receptors antagonists
2) antithymocyte globulin (higher risk of rejection)
3) maintenance drugs at higher doses
Maintenance immunosuppressants
1) CNI (1st tacrolimus; 2nd cyclosporine)
2) Adjuvants w/ CNIs
- antiproliferative agents (mycophenolate or azathioprine) -mTOR inhibitors (everolimus or sirolimus)
- belatacept
3) Steroids
azathioprine is metabolized by
xanthine oxidase inhibitors
*avoid allopurinol and febuxostat
Highest risk of nephrotoxicity
tacrolimus and cyclosporine
Highest risk of increased BG
tacrolimus
steroids
cyclosporine
mTOR inhibitors (everolimus, sirolimus)
Highest risk of worsened lipid parameters
mTOR inhibitors (everolimus, sirolimus)
steroids
cyclosporine
Highest risk of increased BP
tacrolimus
cyclosporine
steroids
All transplant patients must self-monitor for symptoms of infection:
1) Fever of 100.4F (38C) or higher (lower in elderly), chills
2) Cough, more sputum or change in color, sore throat
3) Pain with passing urine, ear or sinus pain
4) Mouth sores or a wound that does not heal
Important vaccines
1) inactivated influenza - annually
2) inactivated pneumococcal (1st PCV13; 2nd PPSV23 - 8 weeks later); then PPSV23 5 years later
3) Varicella - pretransplant ONLY; pt’s close contacts too
**no live vaccines given POST-transplant
Organ transplant complications
1) infection risk - prophylactic drugs used in HIV against OI
2) cancer risk - skin cancer is common (use sunscreen)
3) acute rejection - use high-dose steroids
4) CVD - metabolic syndrome (BP, BG, lipid, wt)
Opportunistic Infections in Transplant patients
1) pneumocystis jirovecii pneumonia
2) Candida
3) CMV